Details for New Drug Application (NDA): 202588
✉ Email this page to a colleague
NDA 202588 describes LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED), which is a drug marketed by Ani Pharms, Rising, and Sandoz, and is included in three NDAs. It is available from one supplier. Additional details are available on the LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) profile page.
The generic ingredient in LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.
The generic ingredient in LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.
Summary for 202588
| Tradename: | LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) |
| Applicant: | Sandoz |
| Ingredient: | amoxicillin; clarithromycin; lansoprazole |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 500MG;500MG;30MG | ||||
| Approval Date: | Mar 4, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
